OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 15, 2017
A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.
The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.
May 09, 2017
Bosch’s Xelum platform is designed for continuous production of oral solid-dosage forms.
May 05, 2017
The program aims to make biosimilars for the treatment of cancer more widely available in middle- and low-income countries.
EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference.
Forecasts were lowered, Reuters reported, due to reduced drug approvals and increased competitive pressures.
May 02, 2017
Learn how to prevent common causes of product loss.
Robotic fill/finish systems reduce human intervention, improve flexibility, and allow more gentle handling of containers.
Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.